Effect and mechanism of allergen-specific immunotherapy on small airway dysfunction in children with asthma

被引:0
|
作者
Zhong, Wenwei [1 ]
Ying, Xiaolan [2 ]
Zhang, Lei [2 ]
Dong, Wenfang [2 ]
Lin, Jie [2 ]
Yang, Lin [3 ]
Hong, Li [3 ,4 ]
Yin, Yong [2 ]
Wu, Jinhong [2 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Pediat, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Resp Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Clin Nutr, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Lab Dept, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
allergen-specific immunotherapy; asthma; basophil; child; small airway dysfunction; SUBCUTANEOUS IMMUNOTHERAPY; EFFICACY; SAFETY;
D O I
10.1002/ppul.27341
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The purpose of this study was to investigate the effectiveness of allergen-specific immunotherapy (AIT) on small airway dysfunction (SAD) and the underlying mechanism with a special focus on basophils. Methods: Sixty-five children with mild to moderate asthma who were under regular inhaled corticosteroid (ICS) treatment for more than 1 year but whose FEF75 remained below 65% of the predicted value and had positive results for serum Der p or Der f were enrolled. Children with asthma underwent house dust mite (HDM) subcutaneous immunotherapy (SCIT) treatment for 1 year. Clinical symptoms and lung function were evaluated every 3 months during HDM SCIT treatment. Basophil activation test (BAT) was carried out before and after HDM SCIT treatment. RNA sequencing was performed in isolated basophils from peripheral blood after 6 months of HDM SCIT treatment, followed by GO term and KEGG pathway enrichment analysis between patients with and without HDM SCIT treatment. Results: HDM AIT treatment ameliorated clinical symptoms while concurrently improved lung function parameters, such as FEV1/FVC, FEF75, FEF50 and MMEF (p < .05). It is worth noting that FEF75 values showed a highly significant, gradual and persistent increase (from 49.55 +/- 1.27% at baseline to 71.89 +/- 2.64% after 1 year of therapy) and 22 of 35 patients no longer had SAD after 1 year of treatment. BAT results revealed that AIT treatment significantly reduced basophil activity to the inhalant allergen mixtures containing HDM in vitro challenge from baseline. GO term and KEGG pathway enrichment analysis of basophils revealed that downregulated genes were mainly involved in immune cell activation, antigen presentation, and Th2 cell differentiation. Conclusions: Our study demonstrated that HDM AIT not only improved SAD related lung function parameters, but also reduced basophil activity. RNA sequencing revealed the inhibition of phagocytosis and the phagosome pathway in basophils which may affect the polarization of Th2 cell differentiation after HDM AIT.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Allergen-Specific Immunotherapy in Asthma
    Jutel M.
    Current Treatment Options in Allergy, 2014, 1 (2) : 213 - 219
  • [2] Allergen-specific immunotherapy for bronchial asthma
    Rosewich M.
    Der Pneumologe, 2018, 15 (3): : 196 - 201
  • [3] Allergen-specific immunotherapy in children
    Maslany, Anna
    Jung, Anna
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2011, 7 (03): : 212 - 217
  • [4] Allergen-specific immunotherapy in children
    El-Sayed, Zeinab A.
    El-Farghali, Ola G.
    EGYPTIAN JOURNAL OF PEDIATRIC ALLERGY AND IMMUNOLOGY, 2012, 10 (02): : 55 - 66
  • [5] Allergen-specific immunotherapy in pediatric allergic asthma
    Yukselen, Ayfer
    ASIA PACIFIC ALLERGY, 2016, 6 (03) : 139 - 148
  • [6] Safety of allergen-specific immunotherapy in children
    De Filippo, Maria
    Votto, Martina
    Caminiti, Lucia
    Panasiti, Ilenia
    Carella, Francesco
    De Castro, Giovanna
    Landi, Massimo
    Olcese, Roberta
    Vernich, Mario
    Marseglia, Gian Luigi
    Ciprandi, Giorgio
    Barberi, Salvatore
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 : 27 - 30
  • [7] The effect of allergen-specific immunotherapy on offspring
    Bozek, Andrzej
    Jarzab, Jerzy
    Bednarski, Piotr
    ALLERGY AND ASTHMA PROCEEDINGS, 2016, 37 (04) : E59 - E63
  • [8] Preventive allergen-specific sublingual immunotherapy in small children induces immunomodulation
    Szepfalusi, Z.
    Bannert, C.
    Ronceray, L.
    Mayer, E.
    Hassler, M.
    Wissmann, E.
    Dehlink, E.
    Gruber, S.
    Graf, A.
    Valenta, R.
    Eiwegger, T.
    Urbanek, R.
    ALLERGY, 2014, 69 : 4 - 4
  • [9] New horizons in allergen-specific immunotherapy in allergic asthma
    Virchow J.C.
    Der Pneumologe, 2017, 14 (5): : 291 - 295
  • [10] Current issues on sublingual allergen-specific immunotherapy in children with asthma and allergic rhinitis
    Zivkovic, Zorica
    Djuric-Filipovic, Ivana
    Zivanovic, Snezana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2016, 144 (5-6) : 345 - 350